Frimpong Clinical Research Service entered the industry of Medical Research in 1992 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417115, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Nesba Frimpong, Owner by calling (215) 340-2777 during business hours. You can also write to the business’ Single Location at 76 Radcliff Drive, Doylestown, Pennsylvania PA 18901. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Frimpong Clinical Research Service |
| Representative: | Nesba Frimpong, Owner |
| Place of Business: | 76 Radcliff Drive, Doylestown, PA 18901 |
| Contact Number: | (215) 340-2777 |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 5417115 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1992 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Frimpong Clinical Research Service is a company operating from Bucks, Pennsylvania providing professional Medical Research and relevant B2B variables. It was founded in 1992 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417115 as Medical Research.
With a current employee count of 1 to 4, Frimpong Clinical Research Service has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Nesba Frimpong, Owner at (215) 340-2777 for related queries, or to locate its Single Location using the coordinates 40.287754,-75.146571.
The Single Location can also be found at the street address 76 Radcliff Drive in Doylestown, Pennsylvania 18901 and can be engaged online through the company website at , the company Twitter , and Facebook page .